Merck, BioMed X extend collaboration in oncology, autoimmunity

By The Science Advisory Board staff writers

May 17, 2021 -- Merck has extended its collaboration with German company BioMed X and will start six additional research projects at the BioMed X Institute. The projects will build on research in oncology -- specifically looking at DNA damage response and RNA splicing -- and autoimmunity -- looking at intestinal epithelial barrier in autoimmune diseases.

The next joint crowdsourcing project will focus on immune senescence and mitochondrial dysfunction in regulatory T cells and other T-cell subsets that are shared in human autoimmunity and aging. Interested parties can submit a project proposal at www.bio.mx/apply before July 11.


Copyright © 2021 scienceboard.net
 


MemberID or email address:

Password:
Forgot your password?